This chapter discusses agents that inhibit platelet function – aspirin, P2Y12 receptor blockers, Gp IIb/IIIa inhibitors, and other agents. The mechanism of actions, indications, and toxicities are listed for each agent.
KeywordsAspirin Abciximab Dipyridamole Gp IIb/IIIa inhibitors Vorapaxar
Suggested Reading (See Also Chap. 20)
- Eikelboom JW, Hirsh J, Spencer FA, Baglin TP, Weitz JI. Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e89S–119S. https://doi.org/10.1378/chest.11-2293.CrossRefPubMedPubMedCentralGoogle Scholar
© Springer Nature Switzerland AG 2019